Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.

MLA

Taylor Touré, Juliette, et al. “Impact of Second-Generation Antipsychotics on the Use of Antiparkinson Agents in Nursing Homes and Assisted-Living Facilities.” American Journal of Geriatric Pharmacotherapy, vol. 4, no. 1, Mar. 2006, pp. 25–35. EBSCOhost, https://doi.org/10.1016/j.amjopharm.2006.03.003.

APA

Taylor Touré, J., Brandt, N. J., Rhona Limcangco, M., & Briesacher, B. A. (2006). Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities. American Journal of Geriatric Pharmacotherapy, 4(1), 25–35. https://doi.org/10.1016/j.amjopharm.2006.03.003

Chicago

Taylor Touré, Juliette, Nicole J. Brandt, M. Rhona Limcangco, and Becky A Briesacher. 2006. “Impact of Second-Generation Antipsychotics on the Use of Antiparkinson Agents in Nursing Homes and Assisted-Living Facilities.” American Journal of Geriatric Pharmacotherapy 4 (1): 25–35. doi:10.1016/j.amjopharm.2006.03.003.